# FDA recall D-0788-2022

> **RemedyRepack Inc.** · Class II · drug recall initiated 2022-04-06.

## Product

Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only,  MFG by: Lupin Pharma, Baltimore, MD 21202.

## Reason for recall

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

## Distribution

Product was distributed to customers in AK and PA.

## Key facts

- **Recall number:** D-0788-2022
- **Recalling firm:** RemedyRepack Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-04-06
- **Report date:** 2022-05-04
- **Termination date:** 2022-05-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Indiana, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0788-2022

## Citation

> AI Analytics. FDA recall D-0788-2022. Retrieved 2026-07-06 from https://api.ai-analytics.org/recall/D-0788-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*